CausalSentinel

Protein Dossier — VEGFC (Vascular endothelial growth factor C)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: joint disorder 0.213 0.0813 0.00875 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.206 0.0805 0.0103 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension 0.0281 0.0113 0.0131 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast 0.114 0.0478 0.0175 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter -0.233 0.104 0.0254 Wald ratio 1 cis NA
Fractured bone site(s): Other bones -0.0683 0.0319 0.0321 Wald ratio 1 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis 0.106 0.0534 0.0466 Wald ratio 1 cis NA
Cancer code self-reported: malignant melanoma 0.125 0.0688 0.0684 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.0324 0.0186 0.081 Wald ratio 1 cis NA
Fracture resulting from simple fall 0.0301 0.018 0.0944 Wald ratio 1 cis NA
Sleep duration 0.00868 0.00534 0.104 Wald ratio 1 cis NA
Diagnoses - main ICD10: J33 Nasal polyp -0.194 0.123 0.114 Wald ratio 1 cis NA
…and 46 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3132_1_1 VEGF-C Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

42 association rows across 28 traits (37 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Serum levels of protein VEGFC 5e-240 rs41278571 1 GCST90088234 no MR -> candidate analysis
Blood protein levels 1e-117 rs112782083 1 GCST006585 no MR -> candidate analysis
VEGFC protein levels 6e-89 rs35029317 2 GCST90471036 no MR -> candidate analysis
Vascular endothelial growth factor C levels (VEGFC.3132.1.1) 1e-46 rs41278571 1 GCST90243320 no MR -> candidate analysis
DKK1/VEGFC protein level ratio 1e-27 rs10020321 1 GCST90314484 no MR -> candidate analysis
Thyroid stimulating hormone levels 2e-24 rs4571283 4 GCST90572789 no MR -> candidate analysis
Hypothyroidism (PheCode 244) 2e-22 rs4690362 2 GCST90475647 no MR -> candidate analysis
Hypothyroidism 3e-22 rs4690362 3 GCST90627749 MR: beta=-0.0226, p=0.468 (cis)
Hypothyroidism NOS (PheCode 244.4) 4e-21 rs4690362 2 GCST90475653 no MR -> candidate analysis
Appendicular lean mass 7e-18 rs6552198 1 GCST90000025 no MR -> candidate analysis
Vascular endothelial growth factor C levels 1e-17 rs112793547 1 GCST90250161 no MR -> candidate analysis
Total testosterone levels 6e-15 rs371162363 2 GCST90012112 no MR -> candidate analysis
…and 16 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 760 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Milroy disease 0.727 established (curated) no MR -> candidate analysis
hypothyroidism 0.872 common-variant locus MR: beta=-0.0226, p=0.468 (cis)
Abnormality of the skeletal system 0.784 common-variant locus no MR -> candidate analysis
thyroid gland disorder 0.673 common-variant locus no MR -> candidate analysis
Alzheimer disease 0.52 common-variant locus no MR -> candidate analysis
stroke disorder 0.419 common-variant locus no MR -> candidate analysis
alcohol drinking 0.434 common-variant locus no MR -> candidate analysis
benign neoplasm 0.396 common-variant locus no MR -> candidate analysis
male reproductive organ cancer 0.396 common-variant locus no MR -> candidate analysis
jaw disease 0.396 common-variant locus no MR -> candidate analysis
exostosis 0.394 common-variant locus no MR -> candidate analysis
brain aneurysm 0.348 common-variant locus no MR -> candidate analysis
chronic intestinal vascular insufficiency 0.33 common-variant locus no MR -> candidate analysis
hereditary disease 0.316 established (curated) no MR -> candidate analysis
adolescent idiopathic scoliosis 0.272 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 14 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Vascular endothelial growth factor C)
gnomAD constraint pLI=1, LOEUF=0.422 — LoF-INTOLERANT
GWAS Catalog 42 unique SNPs / 81 rows
ClinVar 184 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance